Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000305071 | SCV000341204 | uncertain significance | not provided | 2016-04-07 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002487248 | SCV002799671 | uncertain significance | Mitochondrial complex 4 deficiency, nuclear type 3 | 2022-03-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003165752 | SCV003887057 | uncertain significance | Inborn genetic diseases | 2023-02-14 | criteria provided, single submitter | clinical testing | The c.781G>T (p.A261S) alteration is located in exon 6 (coding exon 6) of the COX10 gene. This alteration results from a G to T substitution at nucleotide position 781, causing the alanine (A) at amino acid position 261 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |